For immediate release
Dr. Trent Northen joins Scientific Advisory Board of Radiant Genomics, Inc.
Emeryville, CA, January 23, 2014 – Radiant Genomics, Inc. is proud to announce that Dr. Trent Northen of the Lawrence Berkeley National Labs has joined the Scientific Advisory Board of Radiant Genomics, Inc. Dr. Northen is an expert in ultra high-throughput mass spectrometry and is the inventor of nanostructure-initiator mass spectrometry (NIMS) for which Dr. Northen was honored with a 2013 R&D 100 Award by R&D Magazine. Dr. Northen is also a recipient of the prestigious Presidential Early Career for Scientists and Engineers Award in 2010.
“Dr. Northen provides world-class expertise in ultra high-throughput mass spectrometry and structural elucidation and his knowledge and experience will be an invaluable addition to our Scientific Advisory Board,” says Dr. Jeffrey Kim, CSO of Radiant Genomics. “We look forward to his input and advice as we build the next-generation in natural product discovery platforms.”
About the Company
Radiant Genomics, Inc. was founded in 2012 with the goal of integrating a range of cutting-edge technologies including large-scale sequencing, synthetic biology, bioinformatics, cloud computing, metabolic engineering, and high-throughput analytical chemistry to develop a next-generation industrial platform for natural product discovery, diversification, and production. Radiant Genomics utilizes this platform to develop products in numerous market categories including pharmaceuticals, agriculture, specialty chemicals, and nutraceuticals.